Growth hormone treatment in growth hormone-sufficient and -insufficient children with intrauterine growth retardation/Russell-Silver Syndrome

Hormone Research

Volumn 50, Issue 1, 1998, Pages 22-27

  Azcona, C ^a   Albanese, A ^a   Bareille, P ^a   Stanhope, R ^a,b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

GH insufficiency; GH therapy; Intrauterine growth retardation

Indexed keywords

GROWTH HORMONE;

AGE; ARTICLE; BODY HEIGHT; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROWTH ACCELERATION; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH RATE; HORMONAL THERAPY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MALE; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SHORT STATURE; SILVER RUSSELL SYNDROME;

BODY HEIGHT; CHILD; CHILD, PRESCHOOL; FEMALE; FETAL GROWTH RETARDATION; GLUCAGON; GROWTH; HUMAN GROWTH HORMONE; HUMANS; INFANT; MALE; PROGNOSIS; PUBERTY;

EID: 0031857504     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023196     Document Type: Article

References (43)

1. Silver HK, Kiyasi W, George J, Deamer WC: Syndrome of congenital hemyhypertrophy, shortness of stature, and elevated urinary gonadotrophins. Pediatrics 1953;12:368-375.
2. Russell A: A syndrome of 'intrauterine' dwarfism recognisable at birth with cranio-facial dysostosis, disproportionately short arms, and other anomalies. Proc R Soc Med 1954;47: 1040-1044.
3. Wennergren M, Wennergren G, Vilbergsson G: Obstetric characteristics and neonatal performance in a four-year small for gestational age population. Obstet Gynecol 1988;72:615-620.
4. Kalberg J, Albertsson-Wikland K, Baber FM, Low LCK, Yeung CY: Born small for gestational age: consequences for growth. Acta Paediatr 1996(suppl 417):8-13.
5. Albertsson-Wikland K, Kalberg J: Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatr Scand 1994(suppl 343):23-30.
6. Chaussain JL, Colle M, Ducret JP: Adult height in children with prepubertal short stature secondary to intrauterine growth retardation. Acta Paediatr 1994;399:72-73.
7. Ackland FM, Stanhope R, Eyre C, Hamil G, Jones J, Preece MA: Physiological growth hormone secretion in children with short stature and intrauterine growth retardation. Horm Res 1988;30:241-245.
8. Stanhope R, Ackland F, Hamill G, Clayton J, Jones J, Preece MA: Physiological growth hormone secretion and response to growth hormone treatment in children with short stature and intrauterine growth retardation. Acta Paediatr Scand 1989;349:47-54.
9. Rochiccioli P, Tauber M, Moisan V, Pienkowski C: Investigation of growth hormone secretion in patients with intrauterine growth retardation. Acta Paediatr Scand 1989;349:42-46.
10. Eeckels R, Vanderschueren-Lodeweyckx M, Wolter R: Plasma growth hormone determination in the Silver-Russell syndrome. Helv Paediatr Acta 1970;25:363-370.
11. Albertsson-Wikland K: Growth hormone secretion and growth hormone treatment in children with intrauterine growth retardation: Swedish Paediatric Study Group for Growth Hormone Treatment. Acta Paediatr Scand 1989(suppl 349):35-41.
12. de Waal WJ, Hokken Koelega AC, Stijnen T, de Muinck Keizer Schrama SM, Drop SL: Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation: The Dutch Working Group on Growth Hormone. Clin Endocrinol Oxf 1994;41:621-630.
13. Tanner JM, Whitehouse RH, Hughes PCR, Vince FP: Effect of human growth hormone treatment for 1-7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome and other complaints. Arch Dis Child 1971;46:745-782.
14. Grunt JA, Enriques AR, Daughaday WH, Budd S: Acute and long-term response to hGH in children with idiopathic small-for dates dwarfism. J Clin Endocrinol Metab 1972;35: 157-168.
15. Foley TP, Thompson RG, Shaw M, Baghdassarian A, Nissley SP, Blizzard RM: Growth responses to human growth hormone in patients with intrauterine growth retardation. J Pediatr 1974;84:635-641.
16. Lanes R, Plotnick LP, Lee PA: Sustained effect of human growth hormone therapy on children with intrauterine growth retardation. J Pediatr 1979;84:635-641.
17. Stanhope R, Preece MA, Hamill G: Does growth hormone treatment improve final height attainment of children with intrauterine growth retardation. Arch Dis Child 1991;66: 1180-1183.
18. Chatelain PG on behalf of the International Board of the Kabi Pharmacia International Growth Study: Auxology and response to growth hormone treatment of patients with intrauterine growth retardation or Silver-Russell syndrome: Analysis of data from the Kabi Pharmacia International growth study. Acta Paediatr 1993(suppl 391):79-81.
19. Chernausek SD, Timothy JB, Frank GR: Linear growth response to growth hormone treatment in children with short stature associated with intrauterine growth retardation: The National Cooperative Growth Study experience. J Pediatr 1996;128:S22-27.
20. de Zegher F, Albertsson-Wikland K, Wilton P, Chatelain P, Jonsson B, Lofstrom A, Butenandt O, Chaussain JL: Growth hormone treatment of short children born small for gestational age: Metaanalysis of four independent, randomised, controlled, multicenter studies. Acta Paediatr 1996;417:27-31.
21. Albanese A, Stanhope R: Growth and metabolic data following growth hormone treatment of children with intrauterine growth retardation. Horm Res 1993;39:8-12.
22. Ranke MB, Lindberg A, on behalf of the KIGS International Board: Growth hormone treatment of short children born small for gestational age or with Silver-Russell syndrome: Results from KIGS (Kabi International Growth Study), including the first report on final height. Acta Paediatr 1996(suppl 417):18-26.
23. Kramer MS: Determinants of low birth weight: Methodological assessment and metaanalysis. Bull WHO 1987;65:663-737.
24. Shah A, Stanhope R, Matthew D: Hazards of pharmacological tests of growth hormone secretion in childhood. BMJ 1992;304:173-174.
25. Tanner JM: Growth at Adolescence, ed 2. Oxford, Blackwell, 1962.
26. Tanner JM, Whitehouse RH, Cameron N, Marshall WA, Healy MJR, Goldstein H: Assessment of skeletal maturity and prediction of adult height (TW2 Method), ed 2. London, Academic Press, 1983.
27. Marshall WA, Tanner JM: Variations in the pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
28. Marshall WA, Tanner JM: Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13-23.
29. Freeman JV, Cole TJ, Chinn S, Jones PRM, White EM, Preece MA: Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 1995;73:17-24.
30. Frank GR, Cheung P-T, Horn JA, Alfaro P, Smith EP, Chernausek SD: Predicting the growth hormone response in patients with intrauterine growth retardation. Clin Endocrinol 1996;44:679-685.
31. Tanner JM, Lejarraga H, Cameron N: The natural history of the Silver-Russell syndrome: a longitudinal study of thirty-nine cases. Pediatr Res 1975;9:611-623.
32. Albanese A, Stanhope R: Persistent short stature in children with intrauterine growth retardation: use of growth hormone treatment. Horm Res 1997;48(suppl 1):63-66.
33. Chatelain PG, Job JC, Blanchard J, Ducret JP, Olivier M, Sagnard L, Vanderschueren-Lodeweyckx: Dose dependent catch-up after 2 years of growth hormone treatment in intrauterine growth retardation. J Clin Endocrinol Metab 1994;78:1454-1460.
34. Boguszewski M, Rosberg S, Albertsson-Wikland K: Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children. J Clin Endocrinol Metab 1995;80: 2599-2606.
35. Deiber M, Chatelain P, Naville D, Putet G, Salle B: Functional hypersomatotropism in small for SGA newborns infants. J Clin Endocrinol Metab 1990;68:232-234.
36. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, Frasier SD, Hasegawa Y, Hintz RL, Lafranchi S, Lippe B, Loriaux L, Melmed S, Preece MA, Ranke MB, Reiter EO, Rogol AD, Underwood LE, Werter GA: Diagnostic controversy: Diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 1995;80:1532-1540.
37. Balsamo T, Tassoni P, Cassio A, Colli C, Tassinary D, Cicognani A, Cacciari E: Response to growth hormone therapy in patients with growth hormone deficiency who were small or appropriate in size for gestational age. J Pediatr 1995;126:474-477.
38. Wilton P, Albertsson-Wikland K, Butenandt O, Chaussain JL, de Zegher F, Löfstrom A: Growth hormone treatment induces a dose-dependent catch-up growth in short children born small for gestational age: a summary of four clinical trials. Horm Res 1997;48(suppl 1): 67-71.
39. Gluckman PD, Cutfield W, Harding JE, Milner JE, Jensen E, WoodHall S, Gallaher B, Bauer M, Breier BH: Metabolic consequences of IUGR. Acta Paediatr 1996(suppl 417):3-6.
40. Chatelain PG, Cauderay MC, de Zegher F, Claris O, Salle B, Tauber M, Chaussain JL: Growth hormone secretion and sensitivity in children born small for gestational age. Acta Paediatr 1996(suppl 417):15-16.
41. Wollmann HA, Kirchner T, Enders H, Preece MA, Ranke MB: Growth and symptoms in Silver-Russell syndrome review on the basis of 386 patients. Eur J Paediatr 1995;154:958-968.
42. Preece MA: Puberty in children with intrauterine growth retardation. Horm Res 1997(suppl 1):30-32.
43. Darendediler F, Hindmarsh PC, Brook CGD: Dose-response curves for treatment with biosynthetic growth hormone. J Endocrinol 1990; 125:311-316.